Abstract
Background Acute coronary syndrome (ACS) is characterized by a variable presentation of vessel involvement, which significantly impacts morbidity and mortality rates. In this study, we aimed to investigate the angiographic findings in patients diagnosed with ACS.
Materials and methods We conducted a retrospective cross-sectional study in the Cardiology Unit of the Department of Internal Medicine from January 1, 2022, to December 30, 2022, following ethical approval from the Institutional Review Committee (reference number: 079/080-161). We employed convenience sampling and calculated point estimates along with 95% confidence intervals.
Results Among the 192 patients included in the study, 129 (67.18%) were male, with an average age of 61.29 ± 12.50 years. The most prevalent angiographic findings were triple vessel disease (TVD) in 77 (40.10%) cases and involvement of the left anterior descending artery (LAD) in 157 (81.77%) cases. ST-elevated myocardial infarction (STEMI) was present in 134 (89.23%) cases. Diabetes mellitus was the most common risk factor, present in 122 (63.54%) patients. Complications arose in 44 (22.91%) patients, with arrhythmia occurring in 18 (40.90%) cases. The mean hospital stay was 4.42 ± 1.87 days, and 10 (5.20%) patients unfortunately passed away during their hospitalization
Conclusion Our study revealed that triple vessel disease and involvement of the left anterior descending artery were the most frequent angiographic findings in patients with ACS. Additionally, diabetes mellitus emerged as the predominant modifiable risk factor, potentially contributing to the prevalence of multiple vessel involvement.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Unfunded study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval for study was done by Institutional Review Committee (IRC) of Chitwan Medical College with a reference number of 079/080-161.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
Data will be provided if necessary upon request by the editors.
